Novavax Covid-19 vaccine receives emergency use authorisation in Indonesia
Biotechnology company Novavax said Indonesia has given the world’s first emergency use authorisation for its Covid-19 vaccine.
The vaccine does not require the extremely cold storage temperatures that some other vaccines need, which could allow it to play an important role in boosting supplies in poorer countries around the world.




